A1LB34 Stock Overview
Develops, manufactures, and markets engineered specialty chemicals worldwide. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 2/6 |
Albemarle Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$25.60 |
52 Week High | US$31.11 |
52 Week Low | US$16.48 |
Beta | 1.55 |
11 Month Change | 11.79% |
3 Month Change | 23.31% |
1 Year Change | -5.81% |
33 Year Change | -59.27% |
5 Year Change | n/a |
Change since IPO | 84.78% |
Recent News & Updates
Recent updates
Shareholder Returns
A1LB34 | BR Chemicals | BR Market | |
---|---|---|---|
7D | 4.1% | 6.1% | 0.3% |
1Y | -5.8% | -26.5% | -1.7% |
Return vs Industry: A1LB34 exceeded the BR Chemicals industry which returned -26.5% over the past year.
Return vs Market: A1LB34 underperformed the BR Market which returned -1.7% over the past year.
Price Volatility
A1LB34 volatility | |
---|---|
A1LB34 Average Weekly Movement | 9.5% |
Chemicals Industry Average Movement | 4.2% |
Market Average Movement | 4.4% |
10% most volatile stocks in BR Market | 8.3% |
10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: A1LB34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: A1LB34's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1887 | 9,000 | Jerry Masters | www.albemarle.com |
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Albemarle Corporation Fundamentals Summary
A1LB34 fundamental statistics | |
---|---|
Market cap | R$74.34b |
Earnings (TTM) | -R$11.36b |
Revenue (TTM) | R$37.54b |
2.0x
P/S Ratio-6.5x
P/E RatioIs A1LB34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A1LB34 income statement (TTM) | |
---|---|
Revenue | US$6.50b |
Cost of Revenue | US$7.27b |
Gross Profit | -US$768.73m |
Other Expenses | US$1.20b |
Earnings | -US$1.97b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -16.74 |
Gross Margin | -11.82% |
Net Profit Margin | -30.26% |
Debt/Equity Ratio | 33.0% |
How did A1LB34 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield-10%
Payout RatioDoes A1LB34 pay a reliable dividends?
See A1LB34 dividend history and benchmarksAlbemarle dividend dates | |
---|---|
Ex Dividend Date | Dec 12 2024 |
Dividend Pay Date | Jan 08 2025 |
Days until Ex dividend | 20 days |
Days until Dividend pay date | 47 days |
Does A1LB34 pay a reliable dividends?
See A1LB34 dividend history and benchmarks